MANNINO RAPHAEL J
Known title: Chief Scientific OfficerCIK: 0001196697
Associated companies
Transaction History
| MTNB | ▼ Sell | Other | 462,150 | $0 | 9/3/2021 | View on chart |
| MTNB | ▼ Sell | Other | 462,150 | $0 | 9/3/2021 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
MTNB Listed Among 12 Health Care Stocks Moving After-Market
Matinas Biopharma was included in a Benzinga list of 12 health care stocks that saw movement in Monday's after-market session. This indicates the stock experienced notable trading activity outside regular hours, likely due to recent developments or market sentiment. The company's stock has a wide 52-week range, reflecting its volatile nature.
MTNB Listed Among 12 Health Care Stocks Moving After-Market. Matinas Biopharma was included in a Benzinga list of 12 health care stocks that saw movement in Monday's after-market session. This indicates the stock experienced notable trading activity outside regular hours, likely due to recent developments or market sentiment. The company's stock has a wide 52-week range, reflecting its volatile nature.